Breaking News Instant updates and real-time market news.

TSLA

Tesla

$315.75

-8.26 (-2.55%)

, PG

Procter & Gamble

$78.68

-0.3128 (-0.40%)

10:15
07/19/18
07/19
10:15
07/19/18
10:15

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Underperform from Hold at Needham with analyst Rajvindra Gill saying the stock remains overvalued in spite of its 16% decline from the the June 2017 peak. 2. Procter & Gamble (PG) downgraded to Neutral from Buy at UBS with analyst Steven Strycula saying the company's reinvestment cycle limits earnings and stock upside. 3. Terex (TEX) downgraded to Market Perform from Outperform at Wells Fargo with analyst Andrew Casey saying his crane check was good but not great, with demand appearing to sequentially flatten. 4. Spark Therapeutics (ONCE) downgraded to Sector Perform from Outperform at RBC Capital with analyst Kennen MacKay saying that after a strong run-up in the stock price driven by lofty expectations for the ongoing Phase 1/2 trial of SPK-8011 in patients with hemophilia, achieving mean FVIII expression levels of 30-55% anticipated by the Street could prove "challenging" as "data to date has not indicated clear dose responsiveness." 5. Hyatt (H) downgraded to Hold from Buy at Berenberg with analyst El Kassir saying Hyatt continues to benchmark well on its pipeline, however, there is little scope for future growth to accelerate from current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TSLA

Tesla

$315.75

-8.26 (-2.55%)

PG

Procter & Gamble

$78.68

-0.3128 (-0.40%)

TEX

Terex

$42.93

-1.35 (-3.05%)

ONCE

Spark Therapeutics

$83.34

-1.92 (-2.25%)

H

Hyatt

$81.90

-1.13 (-1.36%)

  • 31

    Jul

  • 01

    Aug

  • 01

    Aug

  • 01

    Aug

  • 07

    Aug

  • 10

    Sep

TSLA Tesla
$315.75

-8.26 (-2.55%)

07/19/18
NEED
07/19/18
DOWNGRADE
NEED
Underperform
Tesla downgraded to Underperform from Hold at Needham
Needham analyst Rajvindra Gill downgraded Tesla to Underperform, stating the stock remains overvalued in spite of its 16% decline from the the June 2017 peak. The analyst cites expectations of slower Model S/X sales amid increased competition and possible cannibalization from Model 3, expiration of credits, slower gross margins improvement with "persistently high" production costs, lower energy segment revenue after recent restructuring, and Tesla's "unsustainable capital structure with a projected $6B free cash flow burn through 2020. Gill further notes that his checks suggest that extended wait times and the expiration of the $7,500 credit are leading more people to ask for refunds than put down deposits on Model 3 cars, with the refund rate also doubling from the 12% in 2017.
07/19/18
NEED
07/19/18
DOWNGRADE
NEED
Underperform
Tesla downgraded to Underperform from Hold at Needham
07/11/18
BOFA
07/11/18
NO CHANGE
Target $180
BOFA
Buy
Tesla sees 5k per week production level as sustainable, says BofA/Merrill
BofA/Merrill analyst John Murphy kept his Buy rating and $180 price target on Tesla after hosting investor meetings with its management which included the Senior Director of Investor Relations Aaron Chews. Murphy says their presentation indicates that not only is the 5K vehicle output per week level sustainable, the company is on its way to building over 6K cars per week by Q3 and 10K per week by mid-2019. The analyst notes however that he is a bit skeptical about that forecast and believes that it will take "some time" before Model 3 output can reach "material scale". Murphy further states that Tesla's announced agreement with Shanghai government to build a factory in the region comes with an opportunity for production capacity expansion as well as a risk around funding with operating cash flows and higher prices due to U.S.-China trade friction.
07/10/18
KEYB
07/10/18
NO CHANGE
KEYB
Sector Weight
Tesla production potential a chance to talk bull case, says KeyBanc
After Bloomberg reported that Tesla is expected to to sign a memorandum of understanding in Shanghai to build a plant in China capable of producing 500,000 vehicle per year, KeyBanc analyst Brad Erickson told investors in a research note that "this is just the kind of announcement and scenario contemplated" in his positive near-term bias, whereby he thinks investors would attribute some incremental value associated with the incremental production well ahead of revenue. Erickson believes the company's formal messaging of China production will come before the company showing more meaningful steps toward Model 3 profitability, as a China factory will likely require an incremental capital raise. The analyst, who has a Sector Weight rating on Tesla shares, sees Tesla delivering about 426,000 vehicles at an average selling price of about $57,600 in 2020, while doing an additional $4.3B in battery revenue at an operating margin of 8%.
PG Procter & Gamble
$78.68

-0.3128 (-0.40%)

07/09/18
07/09/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Hold from Buy at Jefferies with analyst Kevin Grundy saying slowing market growth, volatility in emerging markets, U.S. retail difficulties, the stronger U.S. dollar and "pricing challenges" should drive estimates lower. 2. SeaWorld (SEAS) and Six Flags (SIX) were downgraded to Market Perform from Outperform at Wells Fargo. 3. Walgreens Boots Alliance (WBA) downgraded to Neutral from Buy at Citi with analyst Ralph Giacobbe saying he finds it difficult to argue for "meaningful multiple expansion" given headwinds from industry pressures and a dynamic and changing backdrop. 4. Flowers Foods (FLO) downgraded to Hold from Buy at Vertical Group. 5. Wayfair (W) downgraded to Market Perform from Outperform with the firm citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/09/18
07/09/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GAMESTOP STARTED WITH A BUY: Jefferies analyst Stephanie Wissink started GameStop (GME) with a Buy rating and $18 price target. Her contrarian view on the stock is that under potential new leadership with a well defined vision and execution plan, the stock's valuation, which she feels is "overlooked and overly discounted," could improve. GameStop is higher by 2.5% in midday trading. PIPER SEES CISCO LOSING SECURITY SHARE TO PALO ALTO: Piper Jaffray analyst James Fish says his firm's recent channel survey work across networking and security were weaker than he's seen in past calendar quarters for Cisco Systems (CSCO). Cisco's Security survey results were "especially weak," implying Palo Alto Networks (PANW) is taking market share, the analyst said, although the former remains his top networking pick. He kept an Overweight rating on Cisco shares, which were down almost 1% in midday trading. JEFFERIES DOWNGRADES P&G: Jefferies analyst Kevin Grundy downgraded Procter & Gamble (PG) to Hold from Buy and lowered his price target for the shares to $79 from $83. Slowing market growth, volatility in emerging markets, U.S. retail difficulties, the stronger U.S. dollar and "pricing challenges" should drive estimates lower, Grundy told investors in a research note titled "Tide Unlikely to Turn: Downgrade to Hold as Bull Thesis Wanes." Grundy said he preferred shares of Church & Dwight (CHD) and Energizer (ENR) for exposure to the Home and Personal Care space. TRADE DESK STARTED WITH A SELL: Pivotal Research analyst Brian Wieser initiated Trade Desk (TTD) with a Sell rating and $58 price target, stating that he believes the company can grow rapidly this year but should then see its growth decelerate. He believes its growth will plateau at a size smaller than Criteo's (CRTO), on which Wieser also initiated coverage this morning with a Buy rating. WELLS FARGO DOWNGRADES TWO THEME PARKS: Wells Fargo analyst Timothy Conder downgraded both SeaWorld (SEAS) and Six Flags (SIX) to Market Perform from Outperform, citing valuation, negative seasonal trading patterns, and weather impact, despite ongoing favorable consumer fundamentals and the key Q3 just starting. SeaWorld is trading down 1.3%, while Six Flags is down 1.7% at midday.
07/18/18
UBSW
07/18/18
DOWNGRADE
UBSW
Neutral
Procter & Gamble downgraded to Neutral from Buy at UBS
07/19/18
UBSW
07/19/18
DOWNGRADE
Target $83
UBSW
Neutral
Procter & Gamble downgraded to Neutral from Buy at UBS
UBS analyst Steven Strycula downgraded Procter & Gamble to Neutral with an unchanged price target of $83. The company's reinvestment cycle limits earnings and stock upside, Strycula tells investors in a research note.
TEX Terex
$42.93

-1.35 (-3.05%)

07/10/18
BARD
07/10/18
DOWNGRADE
BARD
Underperform
Terex downgraded to Underperform from Neutral at Baird
07/10/18
BARD
07/10/18
DOWNGRADE
Target $38
BARD
Underperform
Terex downgraded to Underperform from Neutral at Baird
Baird analyst Mircea Dobre downgraded Terex to Underperform, telling investors in a research note that equipment demand is likely to slow as signs of plateauing rental growth emerge. While rental rates are strong, Dobre says recent fleet growth is beginning to become more apparent in flattening utilization and slower rental rates. The analyst believes OEM margins remain under pressure and demand into 2019 is "increasingly at risk." Dobre maintains a $38 price target on shares.
07/19/18
WELS
07/19/18
DOWNGRADE
Target $45
WELS
Market Perform
Terex downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Andrew Casey downgraded Terex to Market Perform with a $45 price target.
07/19/18
07/19/18
DOWNGRADE
Target $45

Market Perform
Terex downgraded to Market Perform on limited upside potential at Wells Fargo
As previously reported, Wells Fargo analyst Andrew Casey downgraded Terex to Market Perform from Outperform on perceived limited upside potential. The analyst notes that his crane check was good but not great, with demand appearing to sequentially flatten. He still likes the path management is pursuing, but he perceives limited upside to his expectations as production/supply chain constraints appear to limit substantial upside.
ONCE Spark Therapeutics
$83.34

-1.92 (-2.25%)

07/09/18
FBCO
07/09/18
NO CHANGE
Target $98
FBCO
Outperform
Spark Therapeutics price target raised to $98 from $75 at Credit Suisse
Credit Suisse analyst Martin Auster raised his price target for Spark Therapeutics to $98 from $75 as he is growing more comfortable with the long-term outlook for SPK-8011 viability ahead of Q3 update. The analyst reiterates an Outperform rating on the shares.
07/16/18
CANT
07/16/18
NO CHANGE
Target $103
CANT
Overweight
Start of Pfizer trial encouraging for Spark Therapeutics, says Cantor Fitzgerald
After Spark Therapeutics (ONCE) announced that partner Pfizer (PFE) initiated a Phase 3 study to evaluate the efficacy and safety of current factor IX prophylaxis replacement therapy in the usual care setting, Cantor Fitzgerald analyst Elemer Piros said he was encouraged that the program transfer is on track and he remains bullish on the fidanacogene elaparvovec program. He reiterates his Overweight rating and $103 price target on Spark shares.
07/19/18
RBCM
07/19/18
DOWNGRADE
RBCM
Sector Perform
Spark Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
07/19/18
RBCM
07/19/18
DOWNGRADE
Target $75
RBCM
Sector Perform
Spark Therapeutics cut to Sector Perform at RBC Capital on SPK-801 concern
As reported earlier, RBC Capital analyst Kennen MacKay downgraded Spark Therapeutics to Sector Perform from Outperform and kept his $75 price target. The analyst notes that after a strong run-up in the stock price driven by lofty expectations for the ongoing Phase 1/2 trial of SPK-8011 in patients with hemophilia, achieving mean FVIII expression levels of 30-55% anticipated by the Street could prove "challenging" as "data to date has not indicated clear dose responsiveness." McKay also cites the possibility of regulatory delays to gain approval for sale of Luxturna among the risks for Spark Therapeutics.
H Hyatt
$81.90

-1.13 (-1.36%)

07/19/18
BREN
07/19/18
DOWNGRADE
BREN
Hold
Hyatt downgraded to Hold from Buy at Berenberg
Berenberg analyst El Kassir downgraded Hyatt to Hold and raised his price target to $87.50 from $83 following 10% outperformance since his upgrade. Kassir said Hyatt continues to benchmark well on its pipeline, however, there is little scope for future growth to accelerate from current levels. Further, the analyst believes that property disposals may moderate from here or alternative investments versus returning cash to shareholders.
06/12/18
NOMU
06/12/18
NO CHANGE
Target $105
NOMU
Buy
Nomura raises price targets in Lodging, sees most upside in Hilton
Nomura Instinet analyst Harry Curtis raised his Lodging sector price targets after rolling forward his estimates to 2019 EBITDA. The analyst sees the most upside in his Buy-rated stocks: Hilton (HLT), Marriott (MAR), Hilton Grand Vacations (HGV), Extended Stay America (STAY) and Playa Hotels & Resorts (PLYA). He raised his price target for Neutral-rated Choice Hotels (CHH) to $88 from $85, Neutral-rated Hyatt (H) to $85 from $76, Hilton Grand Vacations to $52 from $50, Hilton to $105 from $99, Neutral-rated Host Hotels (HST) to $23 from $22 and Marriott to $165 from $159.
05/31/18
JEFF
05/31/18
INITIATION
Target $85
JEFF
Hold
Hyatt initiated with a Hold at Jefferies
Jefferies analyst David Katz started Hyatt Hotels with a Hold rating and $85 price target. The analyst cites the company's ts "mixed" business model, leverage to owned assets, and "inefficient" capital structure for his Hold rating.
03/16/18
RILY
03/16/18
NO CHANGE
Target $84
RILY
Buy
Hyatt target raised to $84 on recent asset sales at B. Riley FBR
B. Riley FBR analyst Bryan Maher raised his price target for Hyatt Hotels (H) to $84 from $80 to reflect the recent asset sales. The analyst believes the sales are being done at attractive valuations for Hyatt and thinks return of capital to shareholders should be a focus in 2018. He keeps a Neutral rating on the shares.

TODAY'S FREE FLY STORIES

LOW

Lowe's

$108.61

-0.39 (-0.36%)

, HD

Home Depot

$192.49

-0.04 (-0.02%)

10:31
05/20/19
05/20
10:31
05/20/19
10:31
On The Fly
Fly Intel: What to watch in Home Depot, Lowe's earnings reports »

Home improvement…

LOW

Lowe's

$108.61

-0.39 (-0.36%)

HD

Home Depot

$192.49

-0.04 (-0.02%)

AMZN

Amazon.com

$1,851.99

-16.33 (-0.87%)

SHLD

Sears

$0.00

(0.00%)

JCP

J.C. Penney

$1.11

-0.035 (-3.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 23

    May

  • 24

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 24

    Jun

TSLA

Tesla

$199.00

-12.02 (-5.70%)

, TROW

T. Rowe Price

$103.87

-0.55 (-0.53%)

10:31
05/20/19
05/20
10:31
05/20/19
10:31
On The Fly
Tesla dips below $200 as analysts voice concern over Model 3 demand »

Shares of Tesla (TSLA)…

TSLA

Tesla

$199.00

-12.02 (-5.70%)

TROW

T. Rowe Price

$103.87

-0.55 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

VRNA

Verona Pharma

$5.90

-0.45 (-7.09%)

10:20
05/20/19
05/20
10:20
05/20/19
10:20
Hot Stocks
Verona Pharma presents expanded analysis of ensifentrine clinical data »

Verona Pharma presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$19.26

-0.38 (-1.93%)

, TBPH

Theravance Biopharma

$20.19

-0.44 (-2.13%)

10:19
05/20/19
05/20
10:19
05/20/19
10:19
Hot Stocks
Theravance, Mylan study highlights possible role of Yupelri in COPD treatment »

Theravance Biopharma…

MYL

Mylan

$19.26

-0.38 (-1.93%)

TBPH

Theravance Biopharma

$20.19

-0.44 (-2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

10:19
05/20/19
05/20
10:19
05/20/19
10:19
Conference/Events
Wolfe Research IT hardware analyst to hold an analyst/industry conference call »

IT Hardware &…

GOOS

Canada Goose

$47.69

-0.65 (-1.34%)

, OSW

OneSpaWorld

$13.55

0.05 (0.37%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

GOOS

Canada Goose

$47.69

-0.65 (-1.34%)

OSW

OneSpaWorld

$13.55

0.05 (0.37%)

ZM

Zoom Video

$86.55

-3.36 (-3.74%)

BYND

Beyond Meat

$88.70

-0.63 (-0.71%)

FMC

FMC Corporation

$74.01

-1.24 (-1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 06

    Jun

AAL

American Airlines

$30.38

-1.38 (-4.35%)

, DAL

Delta Air Lines

$54.07

-0.82 (-1.49%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

AAL

American Airlines

$30.38

-1.38 (-4.35%)

DAL

Delta Air Lines

$54.07

-0.82 (-1.49%)

DB

Deutsche Bank

$7.42

-0.16 (-2.11%)

EV

Eaton Vance

$36.91

-0.895 (-2.37%)

PRA

ProAssurance

$38.42

-0.72 (-1.84%)

CLX

Clorox

$147.09

0.03 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 12

    Jun

  • 12

    Jun

  • 20

    Jun

GD

General Dynamics

$169.82

3.43 (2.06%)

, TGT

Target

$71.62

0.74 (1.04%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

GD

General Dynamics

$169.82

3.43 (2.06%)

TGT

Target

$71.62

0.74 (1.04%)

NPTN

NeoPhotonics

$3.99

0.16 (4.18%)

UAL

United Continental

$81.40

-0.12 (-0.15%)

JACK

Jack in the Box

$82.09

-0.13 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 22

    May

  • 28

    May

  • 29

    May

  • 04

    Jun

  • 12

    Jun

  • 25

    Jun

  • 27

    Jun

  • 08

    Aug

TRN

Trinity Industries

$20.78

-0.15 (-0.72%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Hot Stocks
Trinity Industries announces strategic railcar maintenance network expansion »

Trinity Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 13

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
05/20/19
05/20
10:17
05/20/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
05/20/19
05/20
10:16
05/20/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
05/20/19
05/20
10:15
05/20/19
10:15
Conference/Events
Wolfe Research healthcare analyst to hold analyst/industry conference call »

Healthcare Services…

10:15
05/20/19
05/20
10:15
05/20/19
10:15
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

10:15
05/20/19
05/20
10:15
05/20/19
10:15
General news
Fed's Harker didn't discuss policy or the economy »

Fed's Harker…

10:10
05/20/19
05/20
10:10
05/20/19
10:10
General news
U.S. corporate bond update: several issues are on the docket »

U.S. corporate bond…

FLIC

First Long Island

$22.31

(0.00%)

10:04
05/20/19
05/20
10:04
05/20/19
10:04
Hot Stocks
First Long Island names Janet Verneuille EVP, CRO »

The First of Long Island…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSC

Studio City

$17.00

(0.00%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Studio City falls -7.3% »

Studio City is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNED

Barnes & Noble Education

$3.40

-0.26 (-7.10%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Barnes & Noble Education falls -7.7% »

Barnes & Noble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEYS

Keysight Technologies

$73.76

-8.12 (-9.92%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Keysight Technologies falls -9.8% »

Keysight Technologies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

SMI

SMIC

$5.39

0.38 (7.58%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
SMIC rises 7.6% »

SMIC is up 7.6%, or 38c…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBK

Westpac Banking

$18.98

1.63 (9.39%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Westpac Banking rises 9.2% »

Westpac Banking is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$7.64

1.46 (23.64%)

10:00
05/20/19
05/20
10:00
05/20/19
10:00
Hot Stocks
Sprint rises 23.5% »

Sprint is up 23.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.83

-0.49 (-1.31%)

09:55
05/20/19
05/20
09:55
05/20/19
09:55
Conference/Events
Boston Scientific to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 29

    May

  • 26

    Jun

  • 13

    Nov

UNM

Unum Group

$34.79

-0.01 (-0.03%)

09:55
05/20/19
05/20
09:55
05/20/19
09:55
Conference/Events
Unum Group participates in a conference call with JPMorgan »

Life Insurance Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 23

    May

  • 11

    Jun

RDY

Dr. Reddy's

$36.93

-2.38 (-6.05%)

09:47
05/20/19
05/20
09:47
05/20/19
09:47
Hot Stocks
Dr. Reddy's falls -6.2% »

Dr. Reddy's is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.